Exploring the Link Between C-Reactive Protein and Age-Related Macular Degeneration

Introduction to the Study

In a 2017 study, researchers investigated the relationship between single nucleotide polymorphisms (SNPs) of the C-reactive protein gene and age-related macular degeneration (AMD). The results indicate that C-reactive protein (CRP) does not directly cause macular degeneration. While high levels of this inflammatory biomarker are associated with AMD, it remains unclear whether elevated CRP levels contribute to the condition or are merely a consequence of a common underlying cause.

Previous Research on CRP and AMD

Earlier studies have explored the connection between various forms of the CRP gene and AMD. These gene forms, known as SNPs, differ by a single DNA nucleotide. However, the size of these previous studies may have limited their ability to yield significant results. Continued research is necessary to better understand the role of CRP SNPs in AMD, which could lead to improved prevention, treatment, and management strategies.

Recent Analysis of CRP Genes and Macular Degeneration

Study Overview

A recent analysis published in JAMA Ophthalmology examined the association between CRP SNPs and the risk of AMD. Researchers gathered data from three studies: the European Eye Study (2000-2002), the Cambridge AMD Study (2001-2007), and the Moorfields Eye Hospital AMD Study (2001-2004).

Methodology

In these studies, researchers photographed patients’ retinas and collected blood samples from both AMD patients and unaffected controls. AMD was graded on a scale from 0 to 4:
– Grade 0: No evidence of AMD.
– Grades 1 and 2: Early AMD, indicated by fatty deposits beneath the retina or pigmentation changes.
– Grade 3: Intermediate AMD, characterized by larger deposits and pigmentation changes.
– Grade 4: Late AMD, marked by abnormal blood vessel growth, retinal detachment, or death of light-sensitive cells.

For the EUREYE and Cambridge studies, patients with CRP levels above 10 mg/L were excluded to avoid potential infection interference. The CRP gene SNPs analyzed included rs1205, rs1130864, rs1800947, and rs3093077.

Study Findings

Among the three studies, a total of 1,727 cases of late AMD were identified, including 1,151 neovascular cases, 384 geographic atrophy cases, and 192 mixed cases. A significant association was discovered between geographic atrophy and CRP levels. Controls with 1 or 2 copies of rs1205 exhibited lower CRP levels compared to those without the SNP. In contrast, controls carrying 1 or 2 copies of rs1130864 had higher CRP levels than those without it. No significant associations were observed between CRP levels or SNPs and early or late AMD.

C-Reactive Protein’s Role in Macular Degeneration

Conclusions from the Research

The study’s findings indicate that C-reactive protein does not cause age-related macular degeneration. Although CRP genotype influenced CRP levels and higher CRP levels correlated with geographic atrophy, neither the genotype nor CRP levels were significantly linked to AMD.

The CRP levels measured during the studies reflect a single point in time. Future research may benefit from longitudinal studies to better ascertain the causal relationship between CRP and AMD. Given that CRP is associated with overall inflammation, its levels could have been affected by other inflammatory conditions, such as smoking or cardiovascular disease.

In summary, while an association exists, C-reactive protein does not serve as a causal factor for age-related macular degeneration.

References

Raishard Haynes, MBSCipriani, V. et al. (2017). Association of C-Reactive Protein Genetic Polymorphisms With Late Age-Related Macular Degeneration. JAMA Ophthalmol. doi:10.1001/jamaophthalmol.2017.2191